Neurotech Pharmaceuticals, Inc.
Brad Martin has a strong background in market access and trade within the pharmaceutical industry. Brad is currently working as the Head of Market Access and Trade at Neurotech Pharmaceuticals, Inc., a position they have held since 2023. Prior to that, they served as the Vice President of Market Access, Specialty Trade & Distribution at Taysha Gene Therapies from 2021 to 2023. Brad was also the Senior Director of Gene Therapy, Trade and Distribution at Sarepta Therapeutics from 2019 to 2021. Before that, Brad worked as a National Account Director at AveXis, Inc. from 2017 to 2019 and as a Regional Account Manager at Lundbeck from 2011 to 2017.
Brad Martin attended Northeastern University from 1993 to 1998, where they obtained a Bachelor's Degree in Athletic Training/Trainer.
This person is not in the org chart
This person is not in any offices
Neurotech Pharmaceuticals, Inc.
Neurotech Pharmaceuticals, Inc. is a privately held biotech company located in Cumberland, Rhode Island. Neurotech has spent years developing the science, technology, team and manufacturing behind NT-501. As a result of a unique partnership and clear direction, we are focused on bringing a long-term treatment to Macular Telangiectasia (MacTel) patients. Our team is focused on bringing to market this treatment designed to slow the progression of MacTel and the vision impairments it causes in patients who don't have another treatment option. Our goal is to help these patients sustain their quality of life.